Daniel Cohen - 01 Mar 2023 Form 3 Insider Report for MINERVA SURGICAL INC

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 01 Mar 2023
Net transaction value: $0
SEC form: 3
Accepted by SEC: 14 Mar 2023, 17:37:19 UTC
Source filing: View source filing
Reporting owner signature: /s/ Daniel Cohen

Key filing fact

Daniel Cohen filed Form 3 for MINERVA SURGICAL INC on 14 Mar 2023.

Key facts

This page summarizes Daniel Cohen's Form 3 filing for MINERVA SURGICAL INC.
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 14 Mar 2023, 17:37.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

UTRS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 122,189,638
Date: 01 Mar 2023
Ownership: See Footnote
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares are held by Accelmed Partners II L.P. Accelmed Partners II, LLC ("Accelmed LLC") is the general partner of Accelmed Partners II GP L.P., which is the general partner of Accelmed Partners II L.P. Mr. Cohen is a venture partner of Accelmed LLC and has no voting or dispositive power with respect to the shares held by Accelmed Partners II L.P. Accordingly, Mr. Cohen disclaims any interest in such shares.